Материал: Донсков С.И., Мороков В.А. Группы крови человека. Руководство по иммуносерологии

16.Andresen P.H. Demonstration of Le x substance in saliva of ABH non-secretors // Vox Sang. – 1972.–V.23.–P.262–269.

17.Andresen P.H. The blood group system L. A new blood L2. A case of epistasy within the blood groups //Acta Path. Microdiol. Scand. – 1948. – V. 25. – P. 728–731.

18.Andresen P.H., Andresen A., Jordal K., Henningsen K. Correlation entre le systeme Lewis etlesystemesecreteur-non-secreteur(Recherchessur71families.)//Rev.Hemat.–1950.–

V.5. – P. 305–314.

19.Andresen P.H., Jordal K.An incomplete agglutinin related to the L-(Lewis) system //Acta Path. Microbiol. Scand. – 1949. – V. 26. – P. 636–638.

20.Appelmelk B.J., Simoons-Smit I., Negrini R. et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity // Infect. Immun. – 1996. – V. 64. – P. 2031–2040.

21.Arcilla M.B., Sturgeon P. Lewis and ABH substances in amniotic fluid obtained by amniocentesis // Pediatr. Res. – 1972. – V. 6. – P. 853–858.

22.Arcilla M.B., Sturgeon P. Le x, the spurned antigen of the Lewis blood group system //Vox Sang. – 1974.–V.26.–P.425–438.

23.Arcilla M.B., Sturgeon P. Studies on secretion of blood group substances. II. Observations on the red cell phenotype Le(a −b −x −) // Vox. Sang. – 1973. – V. 25. – P. 72–87

24.Aspinall G.O., Monteiro M.A. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions // Biochemistry. – 1996. – V. 35. – P. 2498–2504.

25.Aspinall G.O., Monteiro M.A., Pang H. et al. Lipopolysaccharide of Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions // Biochemistry. – 1996. – V. 35. – P. 2489–2497.

26.Aubuchon J.P., Davey R.J.,Anderson H.J. et al. Specificity and clinical significance of antiLe x // Transfusion. – 1986. – V. 26. – 302–303.

27.Baer H., Naylor I., Gibbel N., Rosenfield R. E. The production of precipitating antibody in chickens to a substance present in the fluids of non-secretors of blood groupsA, B and O // J. Immunol. – 1959. –V. 82. – P. 183–189.

28.BallS.P.,TongueN.,GibaudA.etal.Thehumanchromosome19linkagegroupFut1(H),FUT2 (SE), LE, LU, PTPD, C3,APOC2, D19S7, and D19S9 //Ann. Hum. Genet. – 1991. – V. 55. –

P.225–233.

29.Barnicot N.A., Lawler S. A study of the Lewis, Kell, Lutheran and P blood group systems and theABH secretion in WestAfrican Negroes //Amer. J. Phys.Anthrop. – 1953. – V. 11. –

P.83–90.

30.BerlinC.,BargatzeR.F.,CampbellJ.J.etal.α4-integrinsmediatelymphocyteattachmentand rolling under physiologic flow // Cell. –1995. –V. 80. – P. 413–422.

31.Bianco I., Silvestroni E., Lawler S. D. et al. Further contributions to the of Lewis and secretor characters // Vox Sang. – 1960. – V. 5. – P. 337–348.

32.Bird G.W.G. ErythrocyteAgglutinins from Plants. Ph. D. Thesis. – London, 1958.

33.Bird G.W.G. Haemagglutinins in seeds // Brit. Med. Bull. – 1959. – V. 15. – P. 165–168.

34.BirdM.I.,FosterM.R.,MalhotraR.Selectins:physiologicalandpathophysiologicalroles// Biochem Soc. Trans. – 1997. – V. 25. – P. 1199–1206.

35.Blaszczyk-Thurin M., Thurin J., Hindsgaul O. et al. Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy //

J.Biol. Chem. – 1971. – V. 262. – P. 372–379.

36.BoettcherB.,KennyR.AquantitativestudyofLe a,A,andHantigensinsalivasofAustralian Caucasians andAborigines // Hum. Hered. – 1971. – V. 21. – P. 334–345.

37.Boren T., Falk P., Roth K.A. et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens // Science. – 1993. – V. 262. – P. 1892–1895.

591

38.Brandley B.K., Swiedler S.J., Robbins P.W. Carbohydrate ligands of de LEC cell adhesion molecules // Cell. – 1990. – V. 63. – P. 861–863.

39.Brendemoen O.J. Development of the Lewis blood group in the newborn. //Acta Path. Microbiol. Scand.–1961.–V.52.–P.55–58.

40.Brendemoen O.J. Fruther studies of agglutination and inhibition in the Le a-Le b system //

J.Lab. Clin. Med. – 1950. – V. 36. – P. 335–341.

41.Brendemoen O.J. Some factors influencing Rh immunization during pregnancy // Acta. Path. Microbiol. Scand. – 1952. – V. 31. – P. 579–583.

42.Brendemoen O.J. Studies of agglutination and inhibition in two Lewis antibodies // J. Lab. Clin. Med. – 1949. – V. 34 – P. 538–542.

43.Brendemoen O.J., Aas K. Hemolytic Transfusion reaction probably caused by anti-Le a // Acta. Med. Scand. – 1952. – V. 141. – P. 458–460.

44.Broadberry E.R., Lin-Chu M. The Lewis blood group system among Chinese in Taiwan // Hum. Hered. – 1991 – V. 41. – P. 290–294.

45.Brockhaus M., Magnani J.L., Herlyn M. et al. Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors //Arch. Biochem. Biophys. – 1982. – V. 217. – P. 647–651.

46.Brown A., Ellis I. O., Embleton M.J. et al. Immunohistochemical localization of Y hapten and the structurally related H type-2 blood group antigen on large-bowel tumours and normal adult tissues//Int.J.Cancer.–1984.–V.33.–P.727–736.

47.Brown P.C., Glynn L.E., Holborow E.J. Lewis a substance in saliva.Aqualitative difference between secretors and non-secretors // Vox Sang. – 1959. – V. 4. – P. 1–12.

48.CagasP.,ByshC.A.DeterminationoftheconformationofLewisbloodgroupoligosaccharidesby simuloationoftodimensionalnuclearOverhauserdata//Biopolimers.–1990.–V.30.–P.1123– 1138.

49.Candelier J.J., Mollicone R., Mennessom B. et al. α-3-Fucosyltransferases and their glycoconjugate antigen products in the developing human kidney // Lab. Invest. – 1993. –

V.69, – P. 449–459.

50.Capron A., Dessaint J.P., Capron M. et al. E. Immunity to schistosomes: progress toward vaccine// Science. – 1987. – V. 238. – P. 1065–1072.

51.Cartron J.P., Mulet C., Bauvois B. et al. ABH and Lewis glycosyltransferases in human red cells,lymphocytes,andplatelets//BloodTransfus.Immunohaemat.–1980.–V.23.–P.271– 282.

52.Ceppellini R. Immunogenetica I0–Analisi fenotypica al livello submolecolare: le specificita’ serologiche multiple dei mucoidi gruppospecifici salivary // Folia Hered. Path. – 1959. – V. 8. – P. 201–226.

53.Ceppellini R. On the genetics of secretor and Lewis characters: a family study // Proc. 5 th Congr. Soc. Blood Transf., Paris, 1955. – P. 207–211.

54.Ceppellini R., Dunn L.C., Innella F. Immunogenetica II. Annalisi genetica formale de

caratteri Lewis con patricolare riguardo alla natura epistatica della specificita’ serologica Le b // Fol. Hered. Path. – 1959. – V. 8. – P. 261–296.

55.Ceppellini R., Siniscalco M. Una nuova ipotesi genetica per il sistema Lewis secretore e suoi riflessi nei riguardi di alcune evidence di linkage con altri loci // Revista dell’Istitutio Sieroterapico Italiano. – 1955. – V. 30. – P. 431–445.

56.ChandanayingyongD.,SasakiT.T.,GdreenwaltT.J.BloodgroupsoftheThais//Transfusion, Philad. – 1967. – V. 7 – P. 269–276.

57.Chester M.A., Watkins W.M. α-L-Fucosyltransferases in human submaxillary gland and stomach tissues associated with the H, Le a and Le b blood group characters and ABH secretor status // Biochem. Biophys. Res. Commun. –1969. – V. 34. – P. 835–842.

58.Comoens H., Sathe M., Joshi V.B. et al. Variations in the Le a in Oh (Bombay) phenotype during pregnancy // Indian J. Med. – 1971. – V. 25. – P. 313–314.

592

59.Cooling L., Gu Y. Identification of two new single-nucleotide polymorphism in FUT3 associated with the Lewis-null phenotype // Transfusion. – 2003. – V. 43. – N 12. –

P.1760–1761.

60.Cowles J.W., Spitalnik S.L., Blumberg N. Detection of anti-Le a in Le(a −b + ) individuals by kinetic ELISA// Vox Sang. – 1986. – V. 50. – P. 164–168.

61.Crookston M.C., Tilley C.A., Crookston J.H. Human blood chimaera with seeming breakdown of immune tolerance // Lancet. – 1970. – V. ii. – P. 1110–1112.

62.Cutbush M., Giblett E.R., Mollison P.L. Demonstration of the phenotype Le(a +b + ) in infants and in adults // Brit. J. Haemat. – 1956. – V. 2 – P. 210–220.

63.Daniels G.L., Anstee D.J., Cartron J.P. et al. ISBT Working party on terminology for red cell surfaceantigens//VoxSang.–2001.–V.80.–P.193–196.

64.De Bose-Boyd R., Nyame A.K., Cummings R.D. Schistosoma mansoni: characterization of an α-1-3-fucjsyltransferase in adult parasites // Exp. Parasit. –1996 – V. 82. – P. 1–10

65.DissousC.,GrzychJ.M.,CapronA.Schistosomamansonisharesaprotectiveoligosaccharide epitope with freshwater and marine snails // Nature. – 1986. – V. 323. – P. 443–445.

66.DorfM.E.,EguroS.Y.,CabreraG.etal.Detectionofcytotoxicnon-HL-Aantisera.I.Relationship toanti-Le a //VoxSang.–1972.–V.22.–P.447–456.

67.Dunstan R.A., Simpson M.B., Knowles R.W., Rosse W.F. The origin of ABH antigens on human platelets// Blood. – 1985. – V. 65. – P. 615–619.

68.Egge H., Hanfland P. Immunochemistry of the Lewis blood group system. Mass spectrometric analysis of permethylated Le a-, Le b-, and H-type 1 (Le dH) blood-group active and related glycosphingolipids from human plasma // Arch. Biochem. Biophys. – 1981. – V. 210. – P. 396–404.

69.Eggens I., Fenderson B., Toyokuni T. et al. Specific interaction between Le x and Le x determinants. A possible basis for cell recognition in preimplanataion embryos and in embryonal carcinoma cells // J. Biol. Chem. – 1989. – V. 264. – P. 9476–9484.

70.Elmgren A., Mollicone R., Costache M. et al. Significance of individual point mutations, T202C and C314T, in the human Lewis (FUT3) gene for expression of Lewis antigens by the human α(1,3 / 1,4)-fucosyltransferase, Fuc-TIII // J. Biol. Chem. – 1997. – V. 272. –

P.21994–21998.

71.Elmgren A., Rydberg L., Larson G. Genotypic heterogeneity among Lewis-negative individuals // Biochem. Biophys. Res. Commun. – 1993. – V. 196. – P. 515–520.

72.Eppenberger-Castori S., Lotscher H., Finn J. Purification of the N-acetylglucosaminide α(1,3 / 4)fucosyltransferase of human milk // Glycoconj. J. – 1989. – V. 6. – P. 101–114.

73.FalkP.G.,BryL.,HolgersonJ.,GordonJ.Expressionofthehumanα-1,3 / 4)-fucosyltransferase in the pit cell lineage of FVB / N mouse stomach result in production of Le b-containing glycoconjugates: a potential transgenic mouse model for studying Helicobacter pylori infection // Proc. Nat.Acad. Sci. USA, 1995. – V. 92. – P. 1515–1519.

74.FeiziP.G.Demonstrationbymonoclonalantibodiesthatcarbohydratestructuresofglycoproteins andglycolipidsareonco-developmentalantigens//Nature.–1985.–V.314.–P.53–57.

75.Feizi P.G., Childs R.A. Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumor-associated antigens and components of receptor system // Trends Biochem. – 1985. – V. 10. – P. 24–29.

76.Fox N., Damjanov I., Knowles B.B., Solter D. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumor // Cancer Res. – 1983. – V. 43. – P. 669–678.

77.Fukushi Y., Hakomori S.I., Nudelman E., Cochran N. Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain // J. Biol. Chem. – 1984. – V. 259. –

P.4681–4685.

593

78.Fukushi Y., Hakomori S.I., Shepard T. Localization and alteration mono-, di-, and trifucosyl α1→3 type 2 chain structures during human embryogenesis and in human cancer // J. Exp. Med. – 1984. – V. 160. – P. 506–520.

79.Fukushima K., Hirota M., Terasaki P.A. et al. Characterization of sialosylated Lewis x as a new tumor-associated antigen // Cancer Res. – 1984. – V. 44. – P. 52–79.

80.Furuhata T., Ueyama R. On the new antigen-antibody ‘T and anti-T precipitin’ // Tokyo Izisinsi. – 1939. – V. 3120. – P. 271–273 (Japan).

81.Galatius-Jensen F. On the genetics of the haptoglobins // Acta Genet. – 1958. – V. 8. –

P.232–247.

82.GarrattyG.,KleinschmidtG.Twoexamplesofanti-Le b detectedintheseraofpatientswith the Lewis phenotype le (a +b −) // Vox Sang. – 1965. – V. 10. – P. 567–571.

83.Gooi H.C., Feizi T., Kapadia A. et al. Stage-specific embryonic antigen involves α1→3 fucosylatedtype2bloodgroupchains//Nature.–1981.–V.292.–P.156–158.

84.Gooi H.C., Picard J.K., Younsell E.F. et al. Monoclonal antibody (EGR / G49) reactive with the epidermal growth factor receptor of A431 cells recognizes the blood group ALe b and ALe y structures // Mol. Immunol. – 1985. – V. 22. – P. 689–694.

85.Gracham D.Y. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease // J. Gastroenterol. – 1991. – V. 6. – P. 105–113.

86.Graham H.A., Hirsch H.F., Davies D.M. Genetics and immunochemical relationships between soluble and cell-bound antigens of the Lewis system // Human Blood Groups /

S.Karger. – Basel, 1977. – P. 257–267.

87.Greenwalt T.J. Confirmation of linkage between the Lutheran and secretor genes // Amer.

J.Hum. Genet. – 1961. – V. 13. – P. 69–88.

88.Greenwell P., Ball M.G., Watkins W.M. Fucosyltransferase activity in human lymphocytes andgranulocytes.BloodgroupH-gene-specifiedα-2-L-fucosyltransferaseisadiscriminatory marker of peripheral blood lymphocytes // FEBS Lett. – 1983. – V. 164. – P. 314–317.

89.Grollman E.F., Kobata A., Ginsburg V. An enzymatic basis for Lewis blood types in man //

J.Clin Invest. – 1969. – V. 48. – P. 1489–1494.

90.GrookstonM.C.,TilleyCA.,GrookstonJH.Humanbloodchimerawithseemingbreakdown of immune tolerance // Lancet. – 1970. – V. ii. – P. 1110–1112.

91.Grubb R. Correlation between Lewis blood group and secretor character in man // Nature.– 1948. – V. 162. – P. 933.

92.Grubb R. Observations on the human group system Lewis. Acta Pat // Microbiol. Scand. – 1951. –V. 28. – P. 61–81.

93.Grubb R. Quelques aspects de la complexite des groupes ABO // Rev. Hemat. – 1950. –

V.5. – P. 268–275.

94.Gundolf F. Anti-A1Le b in serum of a person of a blood group A1h // Vox Sang. – 1973. –

V.25. – P. 411–419.

95.Gunson H.H., Latham V.An agglutinin in human serum reacting with cells from Le(a −b −) non-secretor individuals // Vox Sang. – 1972. – V. 22. – P. 344–353.

96.Hakomori S.I. Aberrant glucosylation and tumor-associated carbohydrate antigens // Adv. Cancer. Res. – 1989. – V. 52. – P. 257–331.

97.Hakomori S.I. Le x and related structures as adhesion molecules // Histochem. – 1992. –

V.24. – P. 771–776.

98.Hakomori S.I. Tumor-associated glycolipid antigens, their metabolism and organization // Chem. Phys. Lipids. – 1986. – V. 42. – P. 209–233.

99.Hakomori S.I., Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers // J. Natl. Cancer Inst. – 1983. – V. 71. – P. 231–251.

100.Hakomori S.I., Kobata A. Blood group antigens // The Antigens / M.S. Sela, ed. – New York:Academic Press, 1974. – V. 2. – P. 79–140.

594

101.Hakomori S.I., Nudelman E., Kannagi R., Levery S.B. The common structure in fucosyllactosaminolipids accumulating in human adenocarcinomas, and its possible absenceinnormaltissues//Biochem.Biophys.Res.Commun.–1982.–V.109.–P.36–44.

102.HakomoriS.I.,NudelmanE., LeveryS.etal.The haptenstructureof developmentallyregulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminarynote//Biochem.Biophys.Res.Commun.–1981.–V.100.–P.1578–1586.

103.Hakomori S.I., Nudelman E., Levery S.B., Kannagi R. Novel fucolipids accumulating in human adenocarcinoma. 1. Glycolipids with dior trifucosylated type 2 chain // J. Biol. Chem. – 1984. – V. 259. – P. 4672–4680.

104.HammarL.,ManssonS.,RohrT.etal.LewisphenotypeoferythrocytesandLe b-activeglycolipid inserumofpregnantwomen//VoxSang.–1981.–V.40.–P.27–33.

105.Hanfland P., Graham H.A. Immunochemistry of the Lewis-blood-group system: partial characterization of Le a-, Le b-, and H-type 1 (Le dH)-blood-group active glycosphingolipids from human plasma //Arch. Biochem. Biophys. – 1981. – V. 210. – P. 383–395.

106.HanflandP.,KordowiczM.,Peter-KatalinicJ.etal.ImmunochemistryoftheLewisblood- group system: isolation and structures of Lewis-c active and related glycosphingolipids from the plasma of blood-group O Le(a −b −) nonsecretors // Arch. Biochem. Biophys. – 1986. – V. 246. – P. 655–672.

107.Henry S.M., Benny A.G., Woodfiled D.G. Investigation of Lewis phenotypes on Polynesians: evidence of a weak secretor phenotype // Vox Sang. – 1990. – V. 58. –

P.61–66.

108.Henry S.M., Simpson L.A., Woodfiled D.G. The Le(a +b + ) phenotype in Polynesians // Hum. Hered. 1988. – V. 38. – P. 111–116.

109.Hirsch H.F., Graham H.A. Adsorption of Le c and Le d from plasma onto red blood cells // Transfusion. – 1980. – V. 20. – P. 474–475.

110.Holburn A.M. IgG anti-Le a // Brit. J. Haematol. – 1974. – V. 27. – P. 489–500.

111.Holburn A.M. Quantitative studies with [125I] IgM anti-Le a // Immunology. – 1973. –

V.24. – P. 1019.

112.Holmes E.H., Ostrander G.K., Clausen H., Graem N. Oncofetal expression of Le x carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation // J. Biol. Chem. – 1987. – V. 262. – P. 11331– 11338.

113.Ilver D., Arnqvist A., Ögren J. et al. Helicobacter pylori adhesin binding fucosylated histoblood group antigens revealed by retagging // Science. – 1998. – V. 279. – P. 373–377.

114.IsekiS.,MasakiS.,ShibasakiK.StudiesonLewisbloodgroupfactor//Proc.Imp.Acad.Japan.– 1957.–V.33.–P.492–497.

115.Issitt P.D., Anstee D.J. Applied Blood Group Serology. – 4-th ed. – Durham, NC, USA: Montgomery Sc. Publ., 1998. – P. 248–275.

116.Iwaki Y., Kasai M., Terasaki P. I. et al. Monoclonal antibody against A1Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma // Cancer Res. – 1982. – V. 42. – P. 409–411.

117.Jeannet M., Bodmer J. G., Bodmer W. F., Schapira M. Lymphocytotoxic sera associated withtheABOandLewisredcellbloodgroups//HistocompatabilityTesting,Munksgaard.– Copenhagen, 1972. – P. 493–499.

118.Jeannet M., Schapira M., Magnin C. Mise en évidence d’anticorps lymphocytotoxiques dirigés contre les antigènes A et B contre des antigènes d’histocompatibilite non HL-A // Schweiz. Med. Wochenschr. – 1974. – V. 104. – P. 152.

119.Jesse J.K., Sheek K.J. Anti-Le b implicated in hemolytic transfusion reaction – a rare occurrence // Transfusion. – 2000. – V. 40. – Suppl. – SP298.

595